Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market – Video

Posted: Published on September 20th, 2014

This post was added by Dr P. Richardson




Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market
HAIFA, Israel, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today it is evaluating...

By: CorporateProfile

Here is the original post:
Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market - Video

Related Posts
This entry was posted in Cell Therapy. Bookmark the permalink.

Comments are closed.